Whereas, researchers initially assessed the expression levels of Dual-Specificity Phosphatase 4 (DUSP4) in HCC cells by analyzing public datasets from HepG2 and Huh7 cell lines and monitoring expression changes post-sorafenib treatment. This evidence concerns the gene DUSP4 and hepatocellular carcinoma.